Exact Sciences Completes Acquisition of Thrive Earlier Detection: Blood-Based Multi-Cancer Screening Becomes a Reality & Eventually the Standard of Care Notes CEO
Chairman and CEO Kevin Conroy said, "Bringing Thrive into the Exact Sciences family marks a giant leap toward blood-based, multi-cancer screening becoming a reality and eventually the standard of care.
Emboline Raises Over $10 Million in Series C Funding: Funds Raised To Be Used to Obtain Initial Commercial Approval of the Emboliner & Launch...
xEmboline recently completed the 3-center, 31-patient SafePass 2 study of the Emboliner™ in New Zealand in which the device met all primary endpoints for safety and technical performance when used during TAVR.
George Farmer, Ph.D., Appointed Chief Financial Officer at PureTech: Experienced Financial Analyst & Biotech Executive Complements the Team
Dr. Farmer will be responsible for all aspects of the Company’s finances, including capital markets strategy and execution, strategic and financial planning, and financial reporting.
Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility
Fujifilm notes the new facility is scheduled to begin process development operations in fall 2021.